Thymopoietin Protein (TMPO) (Transcript Variant 2) (Myc-DYKDDDDK Tag)

Catalog No. ABIN2733921

This Recombinant Thymopoietin protein is produced in HEK-293 Cells.

Quick Overview for Thymopoietin Protein (TMPO) (Transcript Variant 2) (Myc-DYKDDDDK Tag) (ABIN2733921)

Target: Thymopoietin (TMPO)

Protein Type: Recombinant

Origin: Human

Source: HEK-293 Cells

Application: Antibody Production (AbP), Standard (STD)

Purity: > 80 % as determined by SDS-PAGE and Coomassie blue staining

Product Details

Protein Characteristics: Transcript Variant 2

Purification tag / Conjugate: This Thymopoietin protein is labelled with Myc-DYKDDDDK Tag.

Characteristics:

• Recombinant human TMPO / LAP2 (transcript variant 2) protein expressed in HEK293 cells.
• Produced with end-sequenced ORF clone

Application Details

Application Notes: Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays

Comment:

The tag is located at the C-terminal.

Restrictions: For Research Use only

Handling

Concentration: 50 μg/mL

Buffer: 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.

Storage: -80 °C

Storage Comment: Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.

Target Details

Target: Thymopoietin (TMPO)

Alternative Name: Tmpo,lap2

Background: The protein encoded by this gene resides in the nucleus and may play a role in the assembly of the nuclear lamina, and thus help maintain the structural organization of the nuclear envelope. It may function as a receptor for the attachment of lamin filaments to the inner nuclear membrane. Mutations in this gene are associated with dilated cardiomyopathy. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene.

Molecular Weight: 50.5 kDa

NCBI Accession: NP_001027454